Full Text View
Tabular View
No Study Results Posted
Related Studies
Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)
This study is ongoing, but not recruiting participants.
Study NCT00065806   Information provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
First Received: August 1, 2003   Last Updated: May 13, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lupus Erythematosus, Systemic
Additional conditions recognized in this trial
Atherosclerosis
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Autoimmune Diseases
Cardiovascular Diseases
Connective Tissue Diseases
Immune System Diseases
Vascular Diseases
Interventions listed in this trial
Atorvastatin
Placebo atorvastatin
Additional drug interventions recognized in this trial
Hydroxymethylglutaryl-CoA Reductase Inhibitors
More general drug interventions related to this trial
Anticholesteremic Agents
Antilipemic Agents
Antimetabolites
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services